PPP4R2 and acute myeloid leukemia: To this end, we determined overlapping differentially expressed and mutated genes or enriched gene sets obtained by comparison of analyses of 1) AML with high versus low global PPP4R2 expression, 2) CN-AML with 3p microdeletion versus CN-AML without 3p microdeletion, and 3) mutated genes of AML patients with 3p microdeletion (Supplementary Figure 3).